drugset / Trial / NCT01946971

Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)

NCT01946971

Phase 1/2 Completed 12 enrolled Seoul National University Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

This study is crossover study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux.

Timeline

Start
2013-09
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 1 mg/kg Oral